Sangamo Therapeutics (SGMO) Balance Sheet

Click line-items for a historical chart and %

Assets
Cash and cash equivalents	27.99M
Marketable securities
Interest receivable	310K
Accounts receivable	1.48M
Prepaid expenses	1.47M
Total current assets	148.85M
Property and equipment, net	4.88M
Other assets
Total assets	164.98M
Liabilities and stockholders' equity
Accounts payable and accrued liabilities	6.32M
Accrued compensation and employee benefits	2.84M
Deferred revenues	4.71M
Total current liabilities	13.87M
Commitments and contingencies	0
Stockholders' equity:
Common stock, $0.01 par value; 80,000,000 shares authorized, 52,444,457 and 45,377,739 shares issued and outstanding at June 30, 2011 and December 31, 2010, respectively	706K
Additional paid-in capital
Accumulated deficit	-431.29M
Accumulated other comprehensive income / (loss)	77K
Total stockholders' equity	143.84M
Total liabilities and stockholders' equity	164.98M

Entities mentioned with SGMO